Advertisements

Stocking Stuffers

 

Hydralogic Systems Inc. (HLS:CA) Stock Quote

Detailed Quote for HLS Therapeutics Inc. (HLS:CA)
$ 14.45   0.03 (+0.21%) Volume: 106.77k 3:45 PM EST 20-Feb-2019
Today 5d 1m 3m 1y more
Last Price
14.45
Change $
0.03
Change %
0.21%
Tick
  
Bid
14.40
Bid Size
1,000
Ask
N/A
Ask Size
0
Open
14.35
High
14.50
Low
14.25
Prev Close
14.42
Last Trade
02/20/19
Volume
106.77k
52 Wk Hi
16.75
52 Wk Low
7.69000005
Market Cap
394.42m
Ex-Div Date
01/30/19
Div Rate
0.20
Yield
1.3841
Shares
27,295,346
EPS (TTM)
-1.23000001
PE Ratio
N/A
Exchange
TSX
News and Media for HLS Therapeutics Inc. (HLS:CA)
Sector News | Topic News
News for HLS Therapeutics Inc. (HLS:CA)
Tue, Feb 19, 2019
6:30 AM HLS Therapeutics to Present at the 8th Annual SVB Leerink Global Healthcare Conference - Canada Newswire
Wed, Feb 06, 2019
6:30 AM HLS Therapeutics Announces Graduation to the Toronto Stock Exchange - Canada Newswire
Tue, Jan 29, 2019
6:30 AM HLS Therapeutics Receives Conditional Approval to Graduate to the Toronto Stock Exchange - Canada Newswire
Thu, Nov 15, 2018
6:30 AM HLS Therapeutics Announces Q3 2018 Financial Results - Canada Newswire
Mon, Nov 12, 2018
6:30 AM HLS Therapeutics Announces that Amarin's Vascepa \u00AE (icosapent ethyl) Demonstrates 26% Reduction in Key Secondary Composite Endpoint of Cardiovascular Death, Heart Attack and Stroke in REDUCE-IT(TM), which Supports 25% Overall Reduction in Five-Point Major Adverse Cardiovascular Event Primary Composite Endpoint - Canada Newswire
Thu, Nov 01, 2018
6:30 AM HLS Therapeutics to Host 2018 Third Quarter Results Conference Call - Canada Newswire
Mon, Sep 24, 2018
5:30 AM HLS Therapeutics Announces that Amarin's REDUCE-IT(TM) Cardiovascular Outcomes Study of Vascepa\u00AE (icosapent ethyl) Capsules Met Primary Endpoint - Canada Newswire
Wed, Sep 12, 2018
9:02 AM Silicon Valley Bank Serves as Joint Lead Arranger for $125 Million Financing for HLS Therapeutics - PR Newswire
Thu, Sep 06, 2018
6:30 AM HLS Therapeutics Appoints Tim Hendrickson as CFO - Canada Newswire
Wed, Aug 22, 2018
6:08 PM HLS Therapeutics Announces Grant of Stock Options - Canada Newswire
Wed, Aug 15, 2018
6:30 AM HLS Therapeutics Announces Q2 2018 Financial Results - Canada Newswire
Mon, Jul 30, 2018
6:30 AM HLS Therapeutics to Host 2018 Second Quarter Results Conference Call - Canada Newswire
Mon, Jun 25, 2018
6:30 AM HLS Therapeutics Reports Annual Meeting Results - Canada Newswire
Fri, Jun 15, 2018
6:30 AM HLS Therapeutics to Host Annual Shareholder Meeting - Canada Newswire
Wed, May 30, 2018
6:30 AM HLS Therapeutics Enters into Automatic Share Purchase Plan - Canada Newswire
Wed, May 16, 2018
6:30 AM HLS Therapeutics Announces Q1 2018 Financial Results - Canada Newswire
Wed, May 09, 2018
5:00 PM HLS Therapeutics Announces Normal Course Issuer Bid - Canada Newswire
6:30 AM HLS Therapeutics to Host 2018 First Quarter Results Conference Call - Canada Newswire
Mon, May 07, 2018
6:30 AM HLS Appoints Ryan Lennox as General Counsel - Canada Newswire
Thu, Apr 26, 2018
6:30 AM HLS Therapeutics Announces Partial Redemption of Preferred Shares - Canada Newswire
More News for HLS:CA >>

Tags for Hydralogic Systems Inc.

Research stocks or mutual funds related to Hydralogic Systems Inc. by keywords or tags. Find companies that have a similar focus to HLS:CA. The keywords below have been associated to HLS:CA by either user submission or electronic means.

Miscellaneous Intermediation (523910) Common Stock Venture Capital Companies (7125) Financial Services Financial